G 200 Pill - pink round, 11mm
Pill with imprint G 200 is Pink, Round and has been identified as Topiramate 200 mg. It is supplied by Glenmark Generics Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 200
Topiramate
- Imprint
- G 200
- Strength
- 200 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Generics Inc.
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
polysorbate 80,
water,
ferric oxide red,
corn starch,
sodium starch glycolate type A potato,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68462-0110 | Glenmark Pharmaceuticals Inc. |
| 35356-0472 | Lake Erie Medical and Surgical Supply (repackager) |
Related images for "G 200"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,332)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Qudexy XR, Eprontia, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Qudexy XR, Eprontia
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.